Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation.
Renal protection against diabetes-induced pathogenic injuries by multiple exposures to low-dose radiation (LDR) was investigated to develop a novel approach to the prevention of renal disease for diabetic subjects. C57BL/6J mice were given multiple low-dose streptozotocin (STZ; 6 x 60 [corrected] mg/kg) to produce a type 1 diabetes. Two weeks after diabetes onset, some of diabetic mice and age-matched nondiabetic mice were exposed whole body to 25 mGy X-rays every other day for 2, 4, 8, 12, and 16 wk. Diabetes caused a significant renal dysfunction, shown by time-dependent increase in urinary microalbumin (Malb) and decrease in urinary creatinine (Cre), and pathological changes, shown by significant increases in renal structural changes and PAS-positive staining. However, diabetes-induced renal dysfunction and pathological changes were significantly, albeit partially, attenuated by multiple exposures to LDR. Furthermore, LDR protection against diabetes-induced renal dysfunction and pathological changes was associated with a significant suppression of diabetes-increased systemic and renal inflammation, shown by significant increases in serum and renal TNFalpha, ICAM-1, IL-18, MCP-1, and PAI-1 contents. To further explore the mechanism by which LDR prevents diabetes-induced renal pathological changes, renal oxidative damage was examined by Western blotting and immunohistochemical staining for 3-nitrotyrosine and 4-hydroxynonenal. Significant increase in oxidative damage was observed in diabetic mice, but not diabetic mice, with LDR. Renal fibrosis, examined by Western blotting of connective tissue growth factor and Masson's trichrome staining, was also evident in the kidneys of diabetic mice but not diabetic mice with LDR. These results suggest that multiple exposures to LDR significantly suppress diabetes-induced systemic and renal inflammatory response and renal oxidative damage, resulting in a prevention of the renal dysfunction and fibrosis.
School of Public Health of Jilin University, Changchun, China.
Chi
C
Zhang
Yi
Y
Tan
Weiying
W
Guo
Cai
C
Li
Shunzi
S
Ji
Xiaokun
X
Li
Lu
L
Cai
D000419:Albuminuria / Q000652:urine; D000447:Aldehydes / Q000032:analysis; D000818:Animals; D015153:Blotting, Western; D018932:Chemokine CCL2 / Q000097:blood / Q000235:genetics; D003404:Creatinine / Q000652:urine; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D003930:Diabetic Retinopathy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood / Q000235:genetics; D020382:Interleukin-18 / Q000097:blood / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009393:Nephritis / Q000378:metabolism / Q000473:pathology; D012313:RNA / Q000737:chemistry / Q000235:genetics; D011897:Random Allocation; D020133:Reverse Transcriptase Polymerase Chain Reaction; D058258:Serpin E2; D015843:Serpins / Q000097:blood / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000235:genetics; D014443:Tyrosine / Q000031:analogs & derivatives / Q000032:analysis
D000447:Aldehydes; C491768:Ccl2 protein, mouse; D018932:Chemokine CCL2; D020382:Interleukin-18; D058258:Serpin E2; C511869:Serpine2 protein, mouse; D015843:Serpins; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; C002744:3-nitrotyrosine; D014443:Tyrosine; D012313:RNA; D003404:Creatinine; C027576:4-hydroxy-2-nonenal